Last reviewed · How we verify

NCT07166692: ALLIANCE

Evaluation of a Retrieval Augmented Large Language Model as a Diagnostic Copilot in Rheumatology

Completed NA Last updated 8 April 2026
What this trial tests

NA trial testing Prof. Valmed in Diagnosis in 82 participants. Completed in 1 February 2026.

Timeline
12 October 2025
Primary endpoint
1 February 2026
1 February 2026

Quick facts

Lead sponsorPhilipps University Marburg
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment82
Start date12 October 2025
Primary completion1 February 2026
Estimated completion1 February 2026
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Philipps University Marburg

Who can join

Eligibility, any sex, with Diagnosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial evaluates whether providing physicians with access to Prof. Valmed, a clinical decision support medical product, improves identification of rheumatic diseases and formulation of differential diagnoses compared with conventional decision support.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diagnosis

Currently open trials in the same condition.

Other Philipps University Marburg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07166692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing